A new take on growth factor signaling in tamoxifen resistance
Wednesday, June 24, 2009 - 03:21
in Health & Medicine
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.